Sep 18, 2024 • 12:00 EDT

Commensal consortia decolonize Enterobacteriaceae via ecological control

Nov 8, 2023 • 12:00 EST

Microbiome treatments are taking off

Apr 25, 2023 • 12:00 EDT

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

Nov 24, 2022 • 12:00 EST

Seeking therapeutic opportunities amid the complexity of the microbiome

Jul 7, 2022 • 12:00 EDT

Cambridge microbiome company looks beyond fecal transplants

May 2, 2022 • 12:00 EDT

Microbiome therapy for recurrent Clostridioides difficile

Mar 24, 2022 • 12:00 EDT

Find a little help from my (microbial) friends

Oct 5, 2021 • 12:00 EDT

Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment

Jun 17, 2021 • 12:00 EDT

CARB-X 5th Anniversary -- Highlights from the portfolio

Dec 7, 2020 • 12:00 EST

Microbial cocktails raise bar for C. diff. treatments

Nov 20, 2020 • 12:00 EST

Can patients’ gut microbes help fight cancer?

Sep 11, 2020 • 12:00 EDT

First microbiome-based drug clears phase III, in clinical trial turnaround

Aug 5, 2020 • 12:00 EDT

Racing the clock to stop drug-resistant superbugs

Aug 4, 2020 • 12:00 EDT

Increased diversity of gut microbiota during active oral immunotherapy in peanut‐allergic adults

Jul 8, 2020 • 12:00 EDT

Microbiome therapeutics and patent protection

Feb 7, 2020 • 12:00 EST

Drugs From Bugs: Why Gates, Zuck And Benioff Think The Next Blockbusters Will Come From Inside Your Gut

Jan 29, 2020 • 12:00 EST

Fighting Cancer with Microbes

Aug 27, 2019 • 12:00 EDT

Voice of America Episode: Defined Bacterial Consortia for Prevention of CDI Recurrence

May 23, 2019 • 12:00 EDT

Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?

Apr 17, 2019 • 12:00 EDT

Inspired by the microbiome, can poop pills and gut bugs help boost cancer immunotherapy’s effects?

Feb 28, 2019 • 12:00 EST

Mapping Microbiome Manufacturing

Feb 6, 2019 • 12:00 EST

Positive selection: Careful sorting of probiotics may finally pave the way for an FDA approval

Sep 6, 2018 • 12:00 EDT

Vedanta IP estate and scientific cofounder ranked among the top 20 most impactful in biotech in 2017

Jun 18, 2018 • 12:00 EDT

Startup aims to make allies of human gut’s microbes

Apr 18, 2018 • 12:00 EDT

Computer-guided design of optimal microbial consortia for immune system modulation

Nov 2, 2016 • 12:00 EDT

Vedanta Biosciences Featured in Wired

Sep 19, 2016 • 12:00 EDT

Vedanta Biosciences Named to the 2016 Fierce15

Jun 6, 2016 • 12:00 EDT

Vedanta Nabs $50M to Expand Microbiome Into Immune-Boosting Therapies

Jun 6, 2016 • 12:00 EDT

Microbiome Startup Vedanta Gets $50M To Make 'Rationally Defined' Bugs Into Drugs

May 13, 2016 • 12:00 EDT

The White House Office of Science and Technology Policy: Vedanta Participates In the White House OSTP National Microbiome Initiative

Mar 30, 2016 • 12:00 EDT

Vedanta Signs License Agreement with Japanese Researchers

Mar 28, 2016 • 12:00 EDT

How Gut Bacteria Are Shaking Up Cancer Research

Mar 21, 2016 • 12:00 EDT

Gut Microbiome-Derived Metabolites Modulate Intestinal Epithelial Cell Damage and Mitigate Graft-Versus-Host Disease

Sep 28, 2015 • 12:00 EDT

Harnessing the Hordes in the Microbiome

Aug 7, 2015 • 12:00 EDT

Microbial Cocktails Join Fecal Transplants in IBD Treatment Trials

Jul 15, 2015 • 12:00 EDT

Vedanta Featured in "Mining the Microbiome: Are Gut Microbes the Next Big Source of Drugs?"

Jul 10, 2015 • 12:00 EDT

What Will Be the Next Biotech Breakthroughs?

Jul 9, 2015 • 12:00 EDT

Bernat Olle - Ending the War on Microbes

Jun 29, 2015 • 12:00 EDT

Vedanta Biosciences Featured in ‘A Gut Feeling About Immunity’

Jun 25, 2015 • 12:00 EDT

CEO Bernat Olle Honored with Princess of Girona Award from King of Spain

Feb 17, 2015 • 12:00 EST

Among Trillions of Microbes in the Gut, A Few Are Special

Jan 13, 2015 • 12:00 EST

Janssen to Invest Up to $241M in Vedanta to Develop Drug for Imflammatory Bowel Disease

Jan 13, 2015 • 12:00 EST

J&J in Deal to Develop Microbiome Drug for Bowel Diseases

Jan 13, 2015 • 12:00 EST

J&J Takes Another Leap Into Microbiome R&D with $241 Vedanta Pact

Jan 13, 2015 • 12:00 EST

With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome

Sep 23, 2014 • 12:00 EDT

Closing in on Microbiome Therapy

Aug 25, 2014 • 12:00 EDT

Commensal Clostridia Protects Against Food Allergen Sensitization

Feb 10, 2014 • 12:00 EST

Vedanta Profiled in Fast Company

Jan 13, 2014 • 12:00 EST

Johnson & Johnson Innovation and Vedanta Video

Nov 13, 2013 • 12:00 EST

Nature Publication by Vedanta Cofounder Provides New Insights on Mechanism of Action of Vedanta Drug Candidate

Nov 5, 2013 • 12:00 EST

Vedanta Founder Selected Spanish Innovator of the Year Under 35 by MIT Technology Review

Sep 10, 2013 • 12:00 EDT

Commensal Cocktail Suppresses Gut Inflammation

Aug 5, 2013 • 12:00 EDT

Gut Microbiota: Selecting Clostridia Strains That Induce T reg Cells From Gut Microbiota

Jul 20, 2013 • 12:00 EDT

Ruslan Medzhitov: Creative and Conceptual Immunologist

Jul 10, 2013 • 12:00 EDT

T reg Induction by A Rationally Selected Mixture of Clostridia Strains from the Human Microbiota

Jul 10, 2013 • 12:00 EDT

Gut Microbes Treat Illness: Oral Administration of A Cocktail of Bacteria Derived From the Human Gut Reduces Colitis and Allergy-Invoked Diarrhea in Mice

Jul 10, 2013 • 12:00 EDT

A Living Drug Cocktail

Jun 4, 2013 • 12:00 EDT

Vedanta Featured on Huffington Post Live Discussion

May 12, 2013 • 12:00 EDT

Vedanta Profiled In The Boston Globe

Apr 5, 2013 • 12:00 EDT

Vedanta Cofounder Authors Overview of Microbiome Field in Nature Biotechnology

Jun 20, 2012 • 12:00 EDT

NPR Profiles the Human Microbiome "Your Inner Ecosystem" with Bernat Olle